National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 407916

History of Changes from the VAERS Wayback Machine

First Appeared on 12/7/2010

407916
VAERS Form:
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:2009-10-01
Onset:2009-10-01
Submitted:2010-11-05
Entered:2010-11-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute lymphocytic leukaemia, Arthralgia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: No relevant medical history. No allergies.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0680984A

Write-up:This case was reported by a healthcare professional via the foreign regulatory authority (# GB-MHRA-ADR 20722193) and described the occurrence of joint pain in a 13-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 01 October 2009 the subject received 1st dose of CERVARIX (.5 ml, intramuscular) and on 19 November 2009 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). At the end of October 2009, 4 weeks after vaccination with first dose of CERVARIX, the subject experienced joint pain. In December 2009, following 19 November 2009 vaccination with unspecified dose of CERVARIX the patient was diagnosed with leukemia lymphoblastic acute. The regulatory authority stated that the patient ''developed joint pains four weeks after first dose of GARDASIL, at the end of the month. Diagnosed approximately eight weeks later with acute lymphoblastic leukaemia''. The regulatory authority reported that the events were disabling. At the time of reporting the events were unresolved. Developed joint pains four weeks after first dose of GARDASIL, at the end of the month. Diagnosed approximately eight weeks later with acute lymphoblastic leukaemia.


Changed on 9/14/2017

407916 Before After
VAERS Form:(blank) 1
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:2009-10-01
Onset:2009-10-01
Submitted:2010-11-05
Entered:2010-11-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 1 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute lymphocytic leukaemia, Arthralgia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: No relevant medical history. No allergies.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0680984A

Write-up:This case was reported by a healthcare professional via the foreign regulatory authority (# GB-MHRA-ADR 20722193) and described the occurrence of joint pain in a 13-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 01 October 2009 the subject received 1st dose of CERVARIX (.5 ml, intramuscular) and on 19 November 2009 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). At the end of October 2009, 4 weeks after vaccination with first dose of CERVARIX, the subject experienced joint pain. In December 2009, following 19 November 2009 vaccination with unspecified dose of CERVARIX the patient was diagnosed with leukemia lymphoblastic acute. The regulatory authority stated that the patient ''developed joint pains four weeks after first dose of GARDASIL, at the end of the month. Diagnosed approximately eight weeks later with acute lymphoblastic leukaemia''. The regulatory authority reported that the events were disabling. At the time of reporting the events were unresolved. Developed joint pains four weeks after first dose of GARDASIL, at the end of the month. Diagnosed approximately eight weeks later with acute lymphoblastic leukaemia.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=407916&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166